Bijuva vs Estradiol Patch and Progesterone: Which One Actually Fits You?

Disclosure: The HRT Index may earn a commission when readers use certain provider links, but provider fit and evidence always come first. We don’t sell or prescribe medication.

Bijuva vs estradiol patch and progesterone comes down to simplicity versus flexibility. Bijuva is one FDA-approved oral capsule of estradiol and progesterone, made for women with a uterus. The patch route uses a transdermal estradiol patch plus a separate oral micronized progesterone pill — usually cheaper, easier to fine-tune, and tied to a lower clot-risk route.

But here’s what most pages won’t tell you: the cheaper, lower-clot-risk patch is also the one that’s genuinely hard to fill in 2026. So the “obvious” answer isn’t always the one you can actually get. This page shows you exactly who each option fits — and how to get past the catch.

Bijuva vs estradiol patch and progesterone: the quick comparison

Both options give you estradiol and bioidentical progesterone. Bijuva combines them in one swallowed capsule; the patch route delivers estradiol through your skin and adds progesterone as a separate pill. That single difference — swallowed versus through-the-skin — drives almost everything else: clot risk, cost, and how easily your dose can be adjusted.

On this page, “estradiol patch and progesterone” means an FDA-approved estradiol patch plus prescription oral micronized progesterone (brand Prometrium; generics exist) — the same kind of progesterone that’s already inside Bijuva. Same hormones, different route and dose system.

If you only read three rows, read estrogen route, clot/stroke signal, and cash price.

Sources: FDA/DailyMed Bijuva label; FDA labeling-change announcement (Feb 12, 2026); GoodRx and SingleCare price pages; ASHP shortage reporting. Verified June 2026.

What is Bijuva?

Bijuva is a prescription capsule that puts estradiol and bioidentical progesterone into one pill, taken each evening with food. The FDA approved it in 2018 for women with a uterus who have moderate-to-severe hot flashes and night sweats from menopause. It comes in two strengths — 0.5 mg estradiol/100 mg progesterone and 1 mg estradiol/100 mg progesterone — and is made by Mayne Pharma.

Two things make Bijuva different from the patch route. First, it’s oral — you swallow it, so the estrogen passes through your liver before reaching the rest of your body (that matters for clot risk, which we’ll cover). Second, it’s a fixed combination— the estrogen and progesterone come locked together, so a clinician can’t dial one up without the other.

Bijuva is FDA-approved and uses bioidentical hormones — chemically identical to the ones your ovaries used to make. But bioidentical isn’t a claim that it works better or is safer; Bijuva’s own site notes there are no data showing bioidentical hormones are superior to synthetic ones. That’s still a real distinction from compounded“bioidentical” preparations, which are custom-made at compounding pharmacies and haven’t gone through the FDA’s review process.

If your main question is what Bijuva costs, see our full page on Bijuva cost without insurance, or how to get it prescribed online in our Bijuva online prescription guide.

What is “estradiol patch and progesterone”?

It’s not one product — it’s a two-part regimen. A patch delivers estradiol through your skin, and you take progesterone separately as a pill to protect your uterus. A clinician prescribes it this way when you need whole-body (systemic) estrogen and you still have a uterus.

The estradiol patch is a small sticky square you wear and change once or twice a week, depending on the type. It comes in a wide range of strengths — roughly 0.025 to 0.1 mg per day — so your dose can be nudged up or down easily. The progesterone is a separate prescription, most often oral micronized progesterone (brand Prometrium; generics exist), the same kind of progesterone that’s already inside Bijuva.

Why more flexible? Because the two hormones are separate. If your estrogen feels right but the progesterone is making you groggy, your clinician can change just the progesterone. With Bijuva, they’re locked together.

Why less simple? Two prescriptions. A patch to change on schedule. Possible skin irritation. A separate progesterone to remember — many women take it at night, partly because it can make you sleepy (which some actually prefer).

Is Bijuva the same as taking estradiol and progesterone separately?

No. They contain the same two hormones, but they’re not the same product, route, or dose system.It helps to picture three versions of “estradiol + progesterone,” because people mix them up constantly:

1. Bijuva — oral estradiol + oral progesterone, in one capsule. Convenient, brand-only, pricier.
2. Generic oral estradiol + generic progesterone— the same hormone molecules as Bijuva, but as two cheap separate pills (~$25–$70/month combined). Still oral — no clot-risk advantage over Bijuva.
3. Estradiol patch + progesterone — estradiol through the skin + a progesterone pill. The route changes, which is the entire reason to choose the patch.

The shortcut to remember: same progesterone in all three; the estrogen route is what you’re actually deciding.

Is the estradiol patch safer than Bijuva?

For blood clots and stroke, the patch has the edge — but “edge” is the right word, not “safe vs dangerous.” Swallowed estrogen passes through your liver first, which nudges up the proteins that make blood clot. Estrogen through the skin mostly skips that step.

The fair counterpoint for Bijuva. Bijuva uses oral estradiol and progesterone — not the regimen that drove the frightening headlines two decades ago (conjugated equine estrogen + medroxyprogesterone acetate). Bijuva’s own approval-trial analyses reported no clinically meaningful changes in clotting markers compared to placebo. That said, Bijuva is still not for women with a history of clots, stroke, or heart attack — those are contraindications right on its label. So for a woman with no clotting history who wants one simple FDA-approved pill, the oral route is a reasonable trade.

And one thing that’s true for both: oral and transdermal estrogen are generally considered similarly effective for hot flashes. You’re not trading away symptom relief to pick a route. You’re choosing how the estrogen gets in.

How do the costs compare in 2026?

Bijuva is the expensive one. It’s brand-only with no generic, so it runs roughly $260–$355 a month without insurance. A generic estradiol patch plus generic progesterone usually totals about $35–$80 a month with a discount card.You’re largely paying Bijuva’s brand premium for the convenience of a single capsule.

If cost is your dealbreaker but you want bioidentical hormones, the cheapest route is generic oralestradiol + generic progesterone (~$25–$70/month) — but that’s still oral, so it doesn’t buy you the patch’s clot-risk advantage. And these prices don’t include your consult, labs, or any membership fee.

If you have PPO insurance and want to see whether Bijuva is covered, — they’re in-network with most PPO plans and available in all 50 states.

If you’re paying cash and want a flat, predictable price, — its menopause membership runs about $59/month, with medications billed separately at the pharmacy.

Do you need progesterone with an estradiol patch?

If you still have a uterus and use whole-body estrogen, yes — you need endometrial protection, and that’s almost always progesterone.Estrogen on its own thickens the uterine lining over time, which raises the risk of uterine (endometrial) cancer. Progesterone keeps that lining in check. If you’ve had a hysterectomy, you generally don’t need it.

This is exactly why Bijuva is built the way it is: it includes progesterone specifically because it’s made for women with a uterus. And it’s why the patch is almost always prescribed alongside a progesterone pill for the same women.

There’s a telling detail in the 2026 FDA labeling change: when the FDA removed old warnings about heart disease, breast cancer, and dementia, it kept the endometrial-cancer warning on estrogen-alone products. The one risk the FDA did not walk back is the uterine-lining risk — which is the whole reason progesterone is in the picture.

If you’re not sure whether your situation even needs progesterone, use Find My HRT Path to sort it out before you compare providers.

What changes if you’ve had a hysterectomy?

If you’ve had a hysterectomy, Bijuva’s own patient information says you should not use it — because it contains progesterone you don’t need.With no uterus, there’s typically no lining to protect, so many women can use estrogen alone. The better question becomes which estrogen route — patch, pill, gel, or spray — fits your symptoms and risk history.

A few honest nuances: “hysterectomy” can mean your uterus was removed but your ovaries stayed, or both came out — and that changes your hormone picture. And there are exceptions: some women with a history of endometriosis are still advised to add progesterone even after a hysterectomy. This is squarely a clinician conversation.

If you’ve had a hysterectomy and landed here comparing Bijuva to a patch, you may be comparing the wrong things. Ask about estrogen-only HRT options instead — and let the tool point you toward providers who handle that.

What if your main problem is vaginal dryness or painful sex?

If your symptoms are mostly vaginal dryness, burning, or painful sex — without the hot flashes and night sweats — then neither Bijuva nor a systemic patch may be your first move. For vaginal-only symptoms, low-dose local vaginal estrogen is often the first thing to ask about. It treats the tissue directly with very little hormone reaching the rest of your body.

The estradiol patch label itself makes this point: when the only issue is vulvar and vaginal symptoms, topical vaginal products should be considered first. Bijuva is approved specifically for hot flashes and night sweats — not as a vaginal-symptom treatment.

If dryness or painful sex is your real reason for being here, use Find My HRT Path so you don’t end up comparing the wrong kind of HRT.

How do side effects compare — and what’s this about peanuts?

Bijuva’s common side effects include breast tenderness, headache, nausea, vaginal bleeding or spotting, and pelvic pain. The patch route adds possible skin irritation where the patch sticks, plus one thing many people don’t know: Prometrium and many oral progesterone capsules use peanut oil, so they’re off-limits if you have a peanut allergy. Bijuva does not contain peanut oil.

Safety reminder that applies to both: call your clinician right away for unusual vaginal bleeding, chest pain, a sudden severe headache, vision or speech changes, severe leg pain, or trouble breathing.

What the 2026 FDA warning change means for this choice

In February 2026, the FDA removed the old “black box” warnings about heart disease, breast cancer, and dementia from the first six menopause hormone products — and both Bijuva and the progesterone (Prometrium) were on that list.The uterine-cancer warning stayed for estrogen-alone products. It’s a real signal that these therapies were over-warned for two decades — but it doesn’t erase your personal risk, and it doesn’t change that the patch route still carries a lower clot signal.

Important: Bijuva and the progesterone both got the warning removed. The estradiol patch wasn’t in the first batch— so its label may still carry the older warning until its own update comes through. Do not read that as “Bijuva is safer than the patch.” It’s just the order the FDA processed the paperwork. The patch’s clot advantage is unchanged.

The catch nobody warns you about: the 2026 patch shortage

The estradiol patch — the cheaper, lower-clot-risk option — is in a nationwide supply squeeze in 2026.Demand jumped after the FDA dropped the boxed warning, and manufacturers haven’t caught up. Women are reporting delayed refills, surprise brand swaps, and driving around to find their patch.

What this means for your choice — three honest things:

• 1.It's a point in Bijuva's favor right now. If you can't reliably get a patch, a stable supply matters — and the oral route sidesteps the patch problem entirely.
• 2.It's a reason to work with a clinician who can pivot. If your patch is unavailable, a good provider can switch you to a different patch brand, an estradiol gel, a spray, or an oral option without leaving you stuck.
• 3.It's a reason to verify availability before you commit to the patch route, not after.

Some good news for cash-pay patients: Hers has publicly said it secured estrogen-patch supply during the shortage, offering estradiol patch kits from $134/month. If the patch route is your lean but stock is the worry, that’s an option worth checking.

If you’re insured and want care that bills your plan, . If you’re cash-pay and specifically want a patch during the shortage, .

What real users say about Bijuva

Across hundreds of patient reviews, Bijuva lands mid-pack: many women report fast hot-flash relief and better sleep, while a recurring minority report weight gain, headaches, or bloating.Reviews are individual experiences — they can’t tell you how well it will work, or how safe it is, for you.

A complaint that comes up again and again is weight gain or water retention — you deserve to know it going in, even though it doesn’t happen to everyone. Two attributed examples that capture the decision (not proof it works for you): one verified reviewer switched toBijuva after the adhesive on her patches kept irritating her skin — a clean example of why some women prefer the pill. Another wrote that her insurance wouldn’t cover Bijuva, so she used the manufacturer coupon and pays about $50 a month — a real-world look at the cost workaround. Individual stories, not typical results.

Where to get either one prescribed

Both regimens are FDA-approved and widely prescribed through online menopause clinics. We verified these details in June 2026 — re-check specifics at intake, since formularies and states change.

Most telehealth clinicians default to generic estradiol plus generic progesterone, because it’s cheaper and easier to adjust. Brand Bijuva usually makes the most sense when your insurance covers it(where Midi’s insurance billing helps) or when you specifically want the single-capsule format and accept the cost. If a provider doesn’t carry Bijuva, that’s not a red flag — it’s just how the market works.

Can I switch between Bijuva and the patch?

Yes — switching between FDA-approved estrogen forms is routine, but it should be clinician-guided, not done by matching numbers.Your prescriber picks a clinically appropriate starting dose and follow-up plan, then fine-tunes as you settle. Don’t stop or switch on your own, partly so your clot risk and any bleeding stay managed during the change.

Plenty of women move both directions: from Bijuva to a patch (for cost or clot-risk reasons), or from a patch to Bijuva (for simplicity, or to escape adhesive irritation). Expect a short adjustment period, and report any unusual bleeding. The key rule, again: there’s no simple chart that safely maps one to the other — let your clinician do the conversion.

What to verify before you pay for an online consult

Before you commit, confirm three things: your actual price (insurance and pharmacy can swing it by hundreds), whether your clotting history points to the patch, and that your provider prescribes the FDA-approved form you want.The wrong consult isn’t just expensive — it can delay the right care.

What we actually verified for this page

We checked the things you’d want a real person to check: product labels, current public prices, provider claims, and the 2026 regulatory and supply situation. We did not personally take Bijuva, wear a patch, or complete a paid consult — and we don’t medically review individual treatment plans.

Last verified: June 2026

• –Bijuva's FDA/DailyMed label — what it's for, its strengths, dosing, contraindications, the "do not use after hysterectomy" instruction, and its February 2026 boxed-warning removal.
• –The Prometrium (progesterone) label — including the peanut-oil contraindication.
• –Bijuva, estradiol-patch, and progesterone prices from GoodRx, SingleCare, and Drugs.com.
• –The transdermal-vs-oral clot evidence from peer-reviewed studies (including ESTHER) and guidance summaries citing NICE and The Menopause Society.
• –The 2026 estradiol-patch shortage, from CNBC, NBC News, and Hers' public supply statement.
• –Provider details for Midi, Sesame, Hers, and Winona from their own sites.

What we did not verify (and you should check yourself): your exact insurance coverage, your final pharmacy price, whether a specific provider will prescribe Bijuva for you, whether online care suits your medical history, and any individual safety or effectiveness outcome.

Frequently asked questions